MedPath

Doxar

Brand Name: Doxar

Generic Name: Losartan Potassium

Active
Registration Number

DR-XY35051

Dosage Form

Tablet

Issuance Date

October 31, 2023

Expiry Date

October 16, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50mg
PackagingAlu-PVC Blister Pack x 10's (Box of 100's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Angiotensin-2-Receptor Blockers (ARBs)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Losartan PotassiumActive
Monograph: Losartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform